← Leaderboards
Samuel J Gentle
University Of Alabama At Birmingham
$535,478
Attributed
$739,665
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $222.8K · FY2020–25$250K$187.5K$125K$62.5K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$739,665 · 2
By mechanism
R21$408,375 · 1
K23$331,290 · 1
Top collaborators
- Rakesh Pravinchandra Patel2 shared
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Robert L Goldenberg$16,578,724
- Alan Thevenet N. Tita$31,628,801
- Waldemar A. Carlo$27,528,882
- John Franklin Kearney$21,145,276
- Akhil Maheshwari$3,641,533
Others in their field
Other Emerging Leaders on “Research Design”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- John E West · University Of Texas At Austin$114,549,667
- Peter K Fritschel · California Institute Of Technology$78,820,000
- Kevin Urdahl · Seattle Children'S Hospital$72,239,698
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
Research focus
Research DesignHealth Care CostsLeadPulmonary HypertensionMorbidity - Disease RateHigh RiskFutureInfantMortalityPreventPremature InfantMortality RiskLung DiseasesBronchopulmonary DysplasiaAdultData AnalysesBiometryAmericanBiological AvailabilityBaseAdvisory CommitteesAccountingChronic Lung DiseaseChild Care
Grant awards (5)
Therapeutic Strategies for the Management of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension$165,479
K23 · FY2025 · HD · contact PI
Therapeutic Strategies for the Management of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension$155,811
K23 · FY2024 · HD · contact PI
Therapeutic Strategies for the Management of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension$10,000
K23 · FY2024 · HD · contact PI
Oral nitrate metabolism as a predictor for bronchopulmonary in preterm infants$185,625
R21 · FY2021 · HD
Oral nitrate metabolism as a predictor for bronchopulmonary in preterm infants$222,750
R21 · FY2020 · HD